Arnold & Porter Advises Pharmacosmos A/S in Its Merger Agreement With G1 Therapeutics
August 09, 2024
August 09, 2024
WASHINGTON, Aug. 9 -- Arnold and Porter, a law firm, issued the following news:
Arnold & Porter represented Pharmacosmos A/S, a leader in the development of innovative treatments for iron deficiency, in a definitive merger agreement under which Pharmacosmos will acquire G1 Therapeutics Inc., a North Carolina based commercial-stage oncology company focused on delivering next-generation therapies that improve the lives of those affected by cancer, for a total equity value of appro . . .
Arnold & Porter represented Pharmacosmos A/S, a leader in the development of innovative treatments for iron deficiency, in a definitive merger agreement under which Pharmacosmos will acquire G1 Therapeutics Inc., a North Carolina based commercial-stage oncology company focused on delivering next-generation therapies that improve the lives of those affected by cancer, for a total equity value of appro . . .